PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/2942/2/17
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Online Spiolto banner ad (Pulse Today)
A health professional (consultant to a pharmaceutical company) complained in a private capacity about an online rolling banner advertisement for Spiolto (tiotropium and olodaterol) on Pulse Today.T…
Clauses: NONE
🔒 Subscribers only
AUTH/2941/2/17
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A health professional (consultant to a pharmaceutical company; employing company named as Novartis in the report) complained in a private capacity about an email invitation to a live webcast from M…
Clauses: NONE
🔒 Subscribers only
AUTH/2936/2/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Johnson & Johnson
A health professional (consultant to a pharmaceutical company) complained in a private capacity about an online Nicorette (nicotine) advertisement by Johnson & Johnson, published in Pulse (Febr…
Clauses: NONE
🔒 Subscribers only
AUTH/2934/2/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Johnson & Johnson breached Clause 4.4 over Nicorette rolling banner missing prominent PI link on fir
A health professional (consultant to Novartis) complained in a private capacity about a Johnson & Johnson online “rolling banner” advertisement for Nicorette (nicotine) on Pulse online (ref…
Clauses: NONE
🔒 Subscribers only
AUTH/2933/2/17
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Chiesi breached Clause 7.2 over “3 steps per inhalation” claim in Fostair NEXThaler online ad (AUTH/
A health professional (consultant to Novartis, complaint made in a private capacity) complained about a Chiesi online banner advertisement for Fostair (beclomethasone/formoterol) NEXThaler (ref CHN…
Clauses: NONE
🔒 Subscribers only
AUTH/2931/1/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer ‘Ultimate Stop Smoking Roadshow’ invite
A health professional (consultant to a pharmaceutical company) complained in a private capacity about Pfizer materials promoting a January 2017 meeting series (“The ultimate stop smoking roadshow…
Clauses: NONE
🔒 Subscribers only
AUTH/2930/1/17
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Johnson & Johnson
A health professional (acting in a private capacity) complained about an online Pulse “rolling banner” advertisement for Nicorette (nicotine) by Johnson & Johnson (ref UK/NI/16-7663).The ba…
🔒 Subscribers only
AUTH/2960/6/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini website
Following an earlier complaint about A Menarini’s corporate website (AUTH/2949/3/17), a hospital doctor raised further concerns about whether the website had been properly certified and re-certif…
Clauses: NONE
🔒 Subscribers only
AUTH/2949/3/17
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
A. Menarini
A hospital doctor visited A. Menarini’s UK corporate website to find information about, and report, an adverse event relating to Adenuric (febuxostat).The doctor found multiple broken links (incl…
Clauses: NONE
🔒 Subscribers only
AUTH/2990/11/17
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
AbbVie
AbbVie voluntarily admitted that one of its representatives had not taken an appropriate examination within one year of starting employment and had not passed it within the first two years.The repr…
Clauses: 9.1
🔒 Subscribers only
AUTH/2986/10/17
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Teva representative email to private hospital deemed misleading about status (AUTH/2986/10/17)
An anonymous, non-contactable complainant alleged that (July–Oct 2017) a Teva account manager contacted/visited a private hospital and falsely presented him/herself as an authorised adviser/speci…
Clauses: NONE
🔒 Subscribers only
AUTH/2976/9/17
Social Media & Digital Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca breached ABPI Code over
A hospital consultant in anaesthesia and intensive care medicine complained about a promotional email for Qtern (saxagliptin/dapagliflozin) sent by AstraZeneca via a third-party professional networ…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2974/9/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare
An anonymous, non-contactable clinician (appeared to be a pharmacist) complained about a ViiV Healthcare IAS webinar filmed live in Paris (27 July 2017).The webinar was described as mostly about do…
Clauses: NONE
🔒 Subscribers only
AUTH/2972/8/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
UCB website governance failures
An anonymous, non-contactable complainant (stating they were a healthcare journalist) complained about content on the UCB Pharma Ltd UK website and provided annotated screenshots.The website sectio…
Clauses: NONE
🔒 Subscribers only
AUTH/2951/4/17
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi breached ABPI Code over Toujeo “Latest Data” app implying hypoglycaemia benefit from clamp-st
A consultant physician complained about Sanofi’s promotion of Toujeo (insulin glargine 300U/ml) using a digital “Latest Data” iPad app (ref SAGB.TJO.16.12.1140(1)a, March 2017).The app presen…
Clauses: NONE
🔒 Subscribers only
AUTH/3005/12/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Biogen
A 2017 transparency study (published in Current Medical Research & Opinion) assessed whether results of company-sponsored trials linked to EMA-approved 2014 medicines were disclosed within set …
Clauses: NONE
🔒 Subscribers only
AUTH/2988/10/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Employee v Otsuka (AUTH/2988/10/17)
An anonymous complainant (an Otsuka UK employee) raised concerns about a named medical science liaison (MSL) employee’s use of a personal LinkedIn account.The employee had 300+ LinkedIn followers…
Clauses: NONE
🔒 Subscribers only
AUTH/2961/6/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Martindale
Indivior complained about Martindale’s promotion of Espranor (buprenorphine oral lyophilisate) versus Indivior’s Subutex (buprenorphine sublingual tablets). Materials at issue: two detail aids …
Clauses: NONE
🔒 Subscribers only
AUTH/2962/7/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Pierre Fabre publicly reprimanded after uncertified sales meeting slides and incomplete submission t
An anonymous sales representative complained on behalf of a group of reps promoting Toviaz (fesoterodine) about call rates and certification/approval of meetings and materials. Allegations included…
Clauses: NONE
🔒 Subscribers only
AUTH/2958/5/17
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas Europe
Astellas Pharma Europe voluntarily admitted an electronic advertisement for Xtandi (enzalutamide) referred to the medicine as “new” more than 12 months after introduction/availability of the re…
Clauses: 3.2
🔒 Subscribers only
AUTH/2937/2/17
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Merck Serono
An anonymous, non-contactable complainant (described as an oncology nurse specialist) complained about a Merck Serono representative promoting Erbitux (cetuximab).The complainant alleged the repres…
Clauses: NONE
🔒 Subscribers only
AUTH/2883/10/16
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas UK
Astellas UK made a voluntary admission about compliance failings linked to patient support programmes: Fresh Start (Betmiga/mirabegron) and VIP (Vesicare/solifenacin succinate).An Astellas employee…
Clauses: NONE
🔒 Subscribers only
AUTH/2918/12/16
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A former GlaxoSmithKline (GSK) employee complained about an online cost calculator for Relvar Ellipta (fluticasone furoate/vilanterol), ref UK/FFT/0232/15(1), prepared April 2016.The complainant fo…
Clauses: NONE
🔒 Subscribers only
AUTH/2912/12/16
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas Pharma Europe
Astellas Pharma Europe voluntarily admitted that three videos containing Betmiga (mirabegron) product claims had been posted online by third parties, potentially promoting a prescription-only medic…
Clauses: NONE
← Prev 18 19 20 21 22 23 24 Next → Page 21 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews